Skip to main content
CGXU logo
CGXU
(NYSEARCA)
Capital Group International Focus Equity ETF
$35.62-- (--)
Loading... - Market loading

CGXU ETF: Capital Group International Focus Equity ETF - Price, Holdings & Analysis

Capital Group International Focus Equity ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$35.52 - $35.86
52-Week High$36.27
52-Week Low$28.14
Open$35.72
Volume1.46M
Average Volume (3M)978.49K
Assets (AUM)6.10B
Expense Ratio0.54%
Total Holdings89
Inception DateFeb 22, 2022
1 Day Change-0.59%
1 Month Change2.59%
6 Month Change18.46%
YTD Change17.79%
1 Year Change24.41%
52-Week Change25.07%
50-Day MA$34.38
200-Day MA$32.30
RSI59.51
Stochastic %K77.58
Stochastic %D84.40
Annual Dividend$1.98
Dividend Yield5.56%
Last Dividend Ex-DateDec 29, 2026
Dividend Growth YoY408.74%
Years Dividend Growth3

Frequently Asked Questions About Capital Group International Focus Equity ETF

What is the current price of CGXU?

The latest CGXU price is $35.62. The 52-week range is $28.14–$36.27. CGXU has returned 25.1% over the past 52 weeks.

What is the expense ratio for CGXU?

CGXU's annual expense ratio is 0.54%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does CGXU pay dividends?

Yes, CGXU pays a 5.56% dividend yield. The last ex-dividend date was 2026-12-29. View full dividend history in the Dividends section.

What are the top holdings of CGXU?

CGXU's largest holdings are Taiwan Semicon (6.9%), Taiwan Semiconductor Manufacturing Company Limited (6.8%), Softbank Group Corp. (5.0%) (combined weight: 18.7%). The fund holds 89 total positions. View the complete portfolio breakdown in the Holdings section.

How does CGXU compare to similar ETFs?

Compare CGXU (0.54% expense ratio, $6.10B AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.